Synergy CHC Corp. Cost of Revenue
Synergy CHC Corp. (SNYR) reported Cost of Revenue of $1.52 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2026-05-14
- Synergy CHC Corp. cost of revenue for the quarter ending 2026-03-31 was $1.52M, a 24.15% decline year-over-year.
- Synergy CHC Corp. cost of revenue for the quarter ending 2025-12-31 was $3.85M, a 2.03% increase year-over-year.
- Synergy CHC Corp. cost of revenue for the quarter ending 2025-09-30 was $2.33M, a 0.28% decline year-over-year.
- Synergy CHC Corp. cost of revenue for the quarter ending 2025-06-30 was $1.90M, a 22.56% decline year-over-year.
- Synergy CHC Corp. cost of revenue for fiscal 2025 was $10.08M, a 9.95% decline from fiscal 2024.
- Synergy CHC Corp. cost of revenue for fiscal 2024 was $11.19M.
- Synergy CHC Corp. cost of revenue for fiscal 2014 was $5.62K.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-03-31 | $1.52M 10-Q · filed 2026-05-14 | $5.37M derived: sum of 2 quarters · filed 2026-05-14 | $7.70M derived: sum of 3 quarters · filed 2026-05-14 | $9.59M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | $3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $6.18M derived: sum of 2 quarters · filed 2026-04-01 | $8.07M derived: sum of 3 quarters · filed 2026-04-01 | $10.08M 10-K · filed 2026-04-01 |
| 2025-09-30 | $2.33M 10-Q · filed 2025-11-13 | $4.23M derived: sum of 2 quarters · filed 2025-11-13 | $6.23M 10-Q · filed 2025-11-13 | $10.00M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-06-30 | $1.90M 10-Q · filed 2025-08-14 | $3.90M 10-Q · filed 2025-08-14 | $7.67M derived: sum of 3 quarters · filed 2026-05-14 | $10.01M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-03-31 | $2.01M 10-Q · filed 2026-05-14 | $5.78M derived: sum of 2 quarters · filed 2026-05-14 | $8.11M derived: sum of 3 quarters · filed 2026-05-14 | $10.56M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $6.11M derived: sum of 2 quarters · filed 2026-04-01 | $8.55M derived: sum of 3 quarters · filed 2026-04-01 | $11.19M 10-K · filed 2026-04-01 |
| 2024-09-30 | $2.34M 10-Q · filed 2025-11-13 | $4.78M derived: sum of 2 quarters · filed 2025-11-13 | $7.42M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $2.45M 10-Q · filed 2025-08-14 | $5.09M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $2.64M 10-Q · filed 2025-05-15 | |||
| 2014-12-31 | $3.93K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $3.93K derived: sum of 2 quarters · filed 2015-03-31 | $5.62K derived: sum of 3 quarters · filed 2015-03-31 | $5.62K 10-K · filed 2015-03-31 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $1.69K derived: sum of 2 quarters · filed 2014-10-31 | $1.69K 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $1.69K 10-Q · filed 2014-08-28 | $1.69K 10-Q · filed 2014-08-28 | ||
| 2014-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |